Quinidine Availability in the United States

The pharmaceutical manufacturer of quinidine, Eli Lilly, recently announcedExternal that it will no longer be producing IV quinidine gluconate, but plans to continue distributing the product until the current stock expires (March 2019).

As of today, intravenous quinidine gluconate remains available for the treatment of severe malaria. CDC and FDA are developing a strategy to ensure continued access to essential medicine for the treatment of severe malaria in the United States.

More on: Treatment of malaria in the United States